CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
-4.69%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$14.7B
(-6.2%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
23.64%
Holding
885
New
75
Increased
357
Reduced
295
Closed
67
Top Buys
| 1 |
Walt Disney
DIS
|
$85.6M |
| 2 |
Merck
MRK
|
$72.8M |
| 3 |
Adobe
ADBE
|
$52.2M |
| 4 |
Booking.com
BKNG
|
$34.7M |
| 5 |
ServiceNow
NOW
|
$30.1M |
Top Sells
| 1 |
Amgen
AMGN
|
$54M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$44.5M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$36.4M |
| 4 |
Salesforce
CRM
|
$36.2M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$30.1M |
Sector Composition
| 1 | Healthcare | 29.36% |
| 2 | Technology | 26.37% |
| 3 | Financials | 8.78% |
| 4 | Communication Services | 7.86% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Electronic Arts
EA
$42B
| $22.7M | 0.15% |
179,118
-85,329
| -32% | -$10.8M |
|
152
Moderna
MRNA
$9.36B
| $22.4M | 0.15% |
130,250
-39,014
| -23% | -$6.72M |
|
|
HES
153
DELISTED
Hess
HES
| $22.3M | 0.15% |
208,504
+192,239
| +1,182% | +$20.6M |
|
154
Cadence Design Systems
CDNS
$94.6B
| $22.1M | 0.15% |
134,433
-5,486
| -4% | -$902K |
|
155
Fortinet
FTNT
$58.7B
| $22.1M | 0.15% |
323,010
-15,605
| -5% | -$1.07M |
|
|
ITOS
156
DELISTED
iTeos Therapeutics
ITOS
| $22M | 0.15% |
683,812
-73,515
| -10% | -$2.37M |
|
157
Pfizer
PFE
$141B
| $21.2M | 0.14% |
408,741
-34,336
| -8% | -$1.78M |
|
|
TSC
158
DELISTED
TriState Capital Holdings, Inc.
TSC
| $20.9M | 0.14% |
628,274
+420,984
| +203% | +$14M |
|
159
Edwards Lifesciences
EW
$47.7B
| $20.7M | 0.14% |
175,818
+22,278
| +15% | +$2.62M |
|
160
Chipotle Mexican Grill
CMG
$56B
| $20.7M | 0.14% |
652,800
+18,050
| +3% | +$571K |
|
161
Domino's
DPZ
$15.8B
| $20.6M | 0.14% |
50,689
+46,016
| +985% | +$18.7M |
|
162
lululemon athletica
LULU
$23.8B
| $20.5M | 0.14% |
56,138
+6,796
| +14% | +$2.48M |
|
163
Verizon
VZ
$184B
| $20.4M | 0.14% |
400,751
+143,149
| +56% | +$7.29M |
|
164
Bristol-Myers Squibb
BMY
$96.7B
| $20.3M | 0.14% |
278,274
-30,317
| -10% | -$2.21M |
|
165
Nucor
NUE
$33.3B
| $20.3M | 0.14% |
136,518
-43,108
| -24% | -$6.41M |
|
166
Best Buy
BBY
$15.8B
| $19.7M | 0.13% |
216,743
+55,758
| +35% | +$5.07M |
|
167
Intel
INTC
$105B
| $19.7M | 0.13% |
396,590
-301,329
| -43% | -$14.9M |
|
|
KDNY
168
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $19.4M | 0.13% |
1,185,314
+80,412
| +7% | +$1.32M |
|
169
Ascendis Pharma
ASND
$12.1B
| $19.3M | 0.13% |
164,318
-74,104
| -31% | -$8.7M |
|
170
Iovance Biotherapeutics
IOVA
$800M
| $19.2M | 0.13% |
1,152,585
+256,221
| +29% | +$4.27M |
|
171
Charles River Laboratories
CRL
$7.99B
| $19.2M | 0.13% |
67,530
-62,879
| -48% | -$17.9M |
|
|
FRC
172
DELISTED
First Republic Bank
FRC
| $18.9M | 0.13% |
116,738
+65,859
| +129% | +$10.7M |
|
173
Ally Financial
ALLY
$12.6B
| $18.8M | 0.13% |
431,303
+19,099
| +5% | +$830K |
|
174
KLA
KLAC
$111B
| $18.6M | 0.13% |
50,684
+2,151
| +4% | +$787K |
|
175
Ionis Pharmaceuticals
IONS
$9.64B
| $18.5M | 0.13% |
499,547
-437,088
| -47% | -$16.2M |
|